Cardioplegia solution is indicated for myocardial protection during cardiac surgery. It induces controlled cardiac arrest, reducing metabolic demand and protecting heart tissue from ischemic damage. Its use allows surgeons to operate in a stable, bloodless field while preserving myocardial function. Modern formulations provide enhanced protection through optimized electrolyte composition, ensuring better postoperative cardiac recovery and outcomes.